| BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis | 
| Bergner CG, van der Meer F, (...), Stadelmann C | Brain | 2024 | | |
| Towards Treating Multiple Sclerosis Progression |
| Häusler D, Weber MS | Pharmaceuticals | 2024 | | |
| Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks | | Schwake C, Ladopoulos T, (...), Ayzenberg I | Journal of Neurology, Neurosurgery & Psychiatry | 2024 | | |
| Nonvesicular lipid transfer drives myelin growth in the central nervous system |
| Wu J, Kislinger G, (...), Simons M | Nature Communications | 2024 | | |
| White matter aging and its impact on brain function |
| Groh J, Simons M | Neuron | 2024 | | |
| Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury |
| Aljović A, Jacobi A, (...), Bareyre FM | EMBO Molecular Medicine | 2023 | | |
| Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors | | Dybowski S, Torke S, Weber MS | JAMA Neurology | 2023 | | |
| Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency |
| Schlotawa L, Tyka K, (...), Gärtner J | EMBO Molecular Medicine | 2023 | | |
| Membrane lipid remodeling modulates γ-secretase processivity |
| Dawkins E, Derks RJ, (...), Steiner H | Journal of Biological Chemistry | 2023 | | |
| Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation |
| Biljecki M, Eisenhut K, (...), Thaler FS | Neurology-Neuroimmunology & Neuroinflammation | 2023 | | |
10.1093/brain/awae293
39319704
